BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -10.52M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-10.52M | (m) |
| 2026-03-31 | (m) | $-9.57M | (m) |
| 2025-12-31 | (m) | $-10.31M | (m) |
| 2025-09-30 | (m) | $-10.85M | (m) |
| 2025-06-30 | (m) | $-11.45M | (m) |
| 2025-03-31 | (m) | $-11.09M | (m) |
| 2024-12-31 | (m) | $-11.62M | (m) |
| 2024-09-30 | (m) | $-14.23M | (m) |
| 2024-06-30 | (m) | $-12.75M | (m) |
| 2024-03-31 | (m) | $-15.53M | (m) |
| 2023-12-31 | (m) | $-17.19M | (m) |
| 2023-09-30 | (m) | $-16.63M | (m) |
| 2023-06-30 | (m) | $-22.26M | (m) |
| 2023-03-31 | (m) | $-23.98M | (m) |
| 2022-12-31 | (m) | $-24.28M | (m) |
| 2022-09-30 | (m) | $-25.45M | (m) |
| 2022-06-30 | (m) | $-23.93M | (m) |
| 2022-03-31 | (m) | $-23.16M | (m) |
| 2021-12-31 | (m) | $-24.46M | (m) |
| 2021-09-30 | (m) | $-30.08M | (m) |
| 2021-06-30 | (m) | $-29.23M | (m) |
| 2021-03-31 | (m) | $-30.36M | (m) |
| 2020-12-31 | (m) | $-31.81M | (m) |
| 2020-09-30 | (m) | $-27.69M | (m) |
| 2020-06-30 | (m) | $-28.83M | (m) |
| 2020-03-31 | (m) | $-26.34M | (m) |
| 2019-12-31 | (m) | $-23.25M | (m) |
| 2019-09-30 | (m) | $-20.94M | (m) |
| 2019-06-30 | (m) | $-18.49M | (m) |
| 2019-03-31 | (m) | $-16.68M | (m) |
| 2018-12-31 | (m) | $-13.95M | (m) |
| 2018-09-30 | (m) | $-8.29M | (m) |
| 2018-06-30 | (m) | $-7.52M | (m) |
| 2018-03-31 | (m) | $-5.46M | (m) |
| 2017-12-31 | (m) | $-4.95M | (m) |
| 2017-09-30 | (m) | $-5.85M | (m) |
| 2017-06-30 | (m) | $-5.05M | (m) |
| 2017-03-31 | (m) | $-4.98M | (m) |
| 2016-12-31 | (m) | $-4.98M | (m) |
| 2016-09-30 | (m) | $-5.74M | (m) |
| 2016-06-30 | (m) | $-6.74M | (m) |
| 2016-03-31 | (m) | $-8.04M | (m) |
| 2015-12-31 | (m) | $-8.49M | (m) |
| 2015-09-30 | (m) | $-9.83M | (m) |
| 2015-06-30 | (m) | $-9.65M | (m) |
| 2015-03-31 | (m) | $-9.37M | (m) |
| 2014-12-31 | (m) | $-9.25M | (m) |
| 2014-09-30 | (m) | $-7.73M | (m) |
| 2014-06-30 | (m) | $-6.39M | (m) |
| 2014-03-31 | (m) | $-5.93M | (m) |
| 2013-12-31 | (m) | $-4.90M | (m) |
| 2013-09-30 | (m) | $-4.26M | (m) |
| 2013-06-30 | (m) | $-4.33M | (m) |
| 2013-03-31 | (m) | $-3.64M | (m) |
| 2012-12-31 | (m) | $-3.43M | (m) |
| 2012-09-30 | (m) | $-4.27M | (m) |
| 2012-06-30 | (m) | $-4.02M | (m) |
| 2012-03-31 | (m) | $-4.08M | (m) |
| 2011-12-31 | (m) | $-3.92M | (m) |
| 2011-09-30 | (m) | $-1.86M | (m) |
| 2011-06-30 | (m) | $-1.85M | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-2.42M | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | (m) | $-1.78M | (m) |
| 2008-12-31 | (m) | $-3.47M | (m) |
| 2007-12-31 | (m) | $-6.24M | (m) |
| 2006-12-31 | (m) | (m) | (m) |
| 2006-03-31 | (m) | $-3.32M | (m) |
| 2005-03-31 | (m) | $-18.84M | (m) |
| 2004-03-31 | (m) | $-73.00K | (m) |
| 2003-03-31 | (m) | $-47.00K | (m) |
| 2002-03-31 | (m) | $-26.00K | (m) |
| 2001-03-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |